The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action

J Clin Psychiatry. 2000 Nov;61(11):813-4. doi: 10.4088/jcp.v61n1101.
No abstract available

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Butyrylcholinesterase
  • Carbamates / pharmacology
  • Carbamates / therapeutic use
  • Cholinesterase Inhibitors / pharmacology*
  • Cholinesterase Inhibitors / therapeutic use
  • Donepezil
  • Galantamine / pharmacology
  • Galantamine / therapeutic use
  • Humans
  • Indans / pharmacology
  • Phenylcarbamates*
  • Piperidines / pharmacology
  • Receptors, Nicotinic / drug effects
  • Rivastigmine

Substances

  • Carbamates
  • Cholinesterase Inhibitors
  • Indans
  • Phenylcarbamates
  • Piperidines
  • Receptors, Nicotinic
  • Galantamine
  • Donepezil
  • Butyrylcholinesterase
  • Rivastigmine